Sclerosing Intraductal Papilloma of the Breast: Diagnosis and Management

Clinical Presentation

• The American College of Radiology recommends that pathologic nipple discharge (spontaneous, unilateral, single-duct, serous or bloody) should be evaluated for sclerosing intraductal papilloma 1, 2

Diagnostic Approach

• The American College of Radiology suggests that mammography should be the first-line imaging modality for patients ≥40 years when a sclerosing intraductal papilloma is suspected 1, 2
• Mammography may show asymmetrically dilated ducts, a circumscribed subareolar mass, or grouped microcalcifications, according to the American College of Radiology 1
• Ultrasound is more sensitive than mammography and should be performed in all patients with pathologic nipple discharge, as recommended by Praxis Medical Insights 2
• Core needle biopsy is essential for definitive diagnosis, as imaging alone cannot reliably distinguish benign from malignant lesions, according to the American College of Radiology and Ca-A Cancer Journal for Clinicians 1, 3

Management and Malignancy Risk

• Complete surgical excision is the standard management for intraductal papillomas (including sclerosing variants) diagnosed at biopsy, due to a 3-14% risk of malignancy upgrade at final pathology, as recommended by Praxis Medical Insights 2
• Surgical excision provides both definitive diagnosis and treatment, with excellent outcomes and no increased risk of subsequent malignancy for solitary papillomas, according to Praxis Medical Insights 2

Important Clinical Pitfalls

• The American College of Radiology and Ca-A Cancer Journal for Clinicians emphasize that tissue diagnosis is mandatory and imaging characteristics alone should not be relied upon 1, 3
• Any discordance between imaging and pathology findings requires surgical excision, as recommended by Praxis Medical Insights 2